Terkko Navigator / Gastroenterology/ Feeds

Editorial Board

Dual energy CT for evaluation of polycystic kidneys: a multi reader study of interpretation time and diagnostic confidence

Radiomics and radiogenomics of prostate cancer

Cellular Stress Responses and Gut Microbiota in Inflammatory Bowel Disease

Response to Yeomans et al.

Association of mitochondrial displacement loop polymorphisms with diarrhea‐predominant irritable bowel syndrome: A preliminary study

Colonic endoscopic mucosal resection in patients taking anticoagulants: Is heparin bridging therapy necessary?

Deletion of Smad4 reduces hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis progression

Rebleeding rate and risk factors in nonsteroidal anti‐inflammatory drug‐induced enteropathy

Esophageal squamous cell carcinomas in a Malaysian cohort show a lack of association with human papillomavirus

Hepatic subcapsular hematoma breaking into the abdominal cavity after extracorporeal shock wave lithotripsy for pancreatic stones

Issue Information

Issue Information‐ PI

Impact of Klebsiella pneumoniae in lower gastrointestinal tract diseases

Prevention of post‐sphincterotomy bleeding by proton pump inhibitor: A randomized controlled trial

Dyspepsia in non‐steroidal anti‐inflammatory drug users and the effect of preventive measures

Successful eradication of Helicobacter pylori with a herbal medicine, goshuyuto (Wu Zhu Yu Tang), plus rabeprazole after failure of triplet therapy with vonoprazan: A report of three cases

Pancreatic Burkitt's lymphoma presenting as an unusual cause of obstructive jaundice

Caution with iceberg model for colonoscopy in mind! A large easily missed sessile serrated polyp surrounding seemingly diminutive protruded polyp: A case report

Ringer's lactate versus normal saline in acute pancreatitis: A systematic review and meta‐analysis

Role of fecal microbiota transplantation in inflammatory bowel disease

Adjusted Intensive Care Infection Score (ICISΔ)—A new approach for prediction of ascitic fluid infection in patients with cirrhosis

P2‐049: Relationship of hydromorphone controlled release prescribing and hepatitis C incidence in Ontario, Canada

P1‐087: Real world experience of sofosbuvir‐based HCV treatment in Alaska Native/American Indian (AN/AI) persons living in Alaska: the Alaska hepatitis C cohort (AK‐HepC)

P2‐089: Heterogenous distribution of HCV genotypes and outcome of treatment

P1‐167: Hepatitis delta in Brazil

O‐024: A novel CRISPR/Cas9‐based approach to transient activation of intracellular host restriction factors results in strong suppression of hepatitis B virus and degradation of cccDNA

P1‐031: Effects of resistance‐associated variants on NS5B polymerase structure of Hepatitis C virus genotype 1b

P1‐125: Prevalence of antiHEV IgG in Argentina: high geographic variation

P2‐041: Serum levels of novel adipokines in patients with hepatocellular carcinoma

P2‐140: Hepatitis serology among human immunodeficiency virus‐positive patients in Istanbul, Turkey

P1‐079: Liver fibrosis regression after HCV treatment with direct acting antivirals in a community‐based population

P1‐160: HBV and HCV test uptake and correlates among men who have sex with men in China: a nationwide cross‐sectional online survey

LBP‐027: Outreach approach on delivering tailored information about hepatitis B&C to injecting drug users (IDUs) in manner that is understood and establish active monitoring mechanism where service needs of IDUs is identified and linked to requir

P2‐091: Scale up of hepatitis C virus treatment in the era of expanded access to all‐oral direct‐acting antivirals (DAAs): a 9‐year Greek cohort study

O‐017: An immunochromatographic test for measurement of alanine aminotransferase 1 (ALT1) at point‐of‐care

P1‐022: Development of nanoparticulate system for vaccine delivery

P2‐132: Implementation of a hepatitis C elimination plan with a view on access expansion and integrality of viral hepatitis care

P1‐073: Sharing the cure: a comprehensive hepatitis C training program for primary care clinicians

P1‐151: Characteristics of People Diagnosed with Acute and Chronic Hepatitis B Virus Infection Differ by Ethnicity

LBP‐021: Field friendly hepatitis diagnostic

P2‐085: Distribution, diversity, and patterns of hepatitis C virus genotypes in the Middle East and North Africa

O‐010: A phase 2 dose‐optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—analysis from the LOWR HDV‐2 study using the robogene® real‐time qPCR HDV RNA assay

P1‐012: Surface engineered vesicular carriers for transmucosal immunization via the nasal route

P1‐121: Evaluation of peripheral immune response during acute cholestatic Hepatitis E infection

P2‐125: Reiki: antiviral therapy?

P2‐036: Time trends in liver transplantation for primary biliary cholangitis in europe over the past three decades

P1‐075: HCC recurrence in HCV patients after liver transplantation in the DAA treatment era: SiLVER Study subgroup analysis reveals sirolimus treatment in combination with CNIs is an excellent treatment option

P1‐154: Integration of hepatitis B screening and prevention into ante‐natal care and delivery services in an urban cohort in Mozambique

O‐013: Hepatic fibrosis measured by elastography among HIV‐infected and HIV‐uninfected people who inject drugs (PWID)